---

GLUE EAR (OTITIS MEDIA WITH EFFUSION — OME)

A Comprehensive 50-Mark Answer

---

1. DEFINITION

Harrison's (p. 1060): "OME, also called serous otitis media, occurs when there is fluid in the middle ear but no acute infection."

---

2. EPIDEMIOLOGY

• Most common cause of acquired conductive hearing loss in children (Dhingra's ENT)

• 60% of cases occur in children <2 years old (Harrison's, p. 1060)

• Seasonal peaks in winter and spring (higher viral URTI prevalence)

---

3. ETIOLOGY AND PREDISPOSING FACTORS

A. Primary Causes

1. Eustachian tube dysfunction (most important — all textbooks)
2. Sequela of Acute Otitis Media (AOM) — most common precipitant
3. Viral upper respiratory tract infections (URTI)

B. Predisposing Factors (Harrison's p. 1060; Scott-Brown's)

---

4. PATHOPHYSIOLOGY

The Eustachian Tube (ET) — Central to Understanding OME

1. Pressure equalization (ventilation of the middle ear)
2. Drainage (mucociliary clearance of middle ear secretions to nasopharynx)
3. Protection (prevents ascending infection from nasopharynx)

Pathogenic Sequence (Scott-Brown's, Hazarika, Zakir Hussain)

EUSTACHIAN TUBE DYSFUNCTION
           ↓
  Impaired ventilation of middle ear
           ↓
  Negative middle ear pressure (retraction)
           ↓
  Transudation of fluid from mucosal blood vessels
           ↓
  Metaplasia of middle ear epithelium
  (cuboidal → secretory columnar epithelium with goblet cells)
           ↓
  Mucous gland hypertrophy + increased mucin production
           ↓
  Accumulation of thick, viscous "glue" (mucoid effusion)
           ↓
  GLUE EAR — Chronic OME

Molecular Pathogenesis (Recent Advances)

• Biofilm formation: Haemophilus influenzae, S. pneumoniae, M. catarrhalis form biofilms on middle ear mucosa — culture-negative on standard tests but detectable by PCR (Post et al., 2001; Hall-Stoodley et al., 2006)
• Mucosal cytokines: IL-1β, IL-6, IL-8, TNF-α, and TGF-β promote goblet cell metaplasia and mucin hypersecretion (MUC5B, MUC5AC)
• Innate immune dysregulation: Toll-like receptors (TLR2, TLR4) activation perpetuates inflammatory signaling
• Mucin gene upregulation: MUC5B gene overexpression correlates with viscosity of effusion

---

5. TYPES OF EFFUSION (Dhingra's; Scott-Brown's)

---

6. PATHOLOGICAL CHANGES (Stell & Maran's; Cummings)

Tympanic Membrane

• Retraction: negative middle ear pressure → atelectasis
• Amber/blue discoloration: visible fluid level
• Dullness and opacity: loss of light reflex
• Radial blood vessels on drum surface
• Reduced or absent mobility on pneumatic otoscopy

Middle Ear Mucosa

• Goblet cell hyperplasia
• Mucous gland hypertrophy
• Subepithelial edema
• Fibroblast proliferation (in chronic cases)

Ossicular Chain

• Initially intact; in chronic cases — fibrous adhesions, tympanosclerosis, erosion of long process of incus

---

7. CLINICAL FEATURES

Symptoms

Signs

• Dull, retracted tympanic membrane (most consistent sign)
• Loss of light reflex or cone of light distorted
• Air-fluid level visible through TM (serous effusion)
• Amber/blue/yellow discoloration of TM
• Immobile TM on Siegel's/pneumatic otoscopy
• Radial blood vessels visible on TM surface (Bailey & Love's, p. 778)

---

8. OTOSCOPIC FINDINGS — DIAGRAM

Bailey & Love's (p. 778): "The otoscopic findings of exudative glue ear are of a dull drum that is immobile on pneumatic otoscopy. The tympanic membrane is retracted and radial blood vessels may be present."

---

9. DIAGNOSIS

A. Otoscopy / Pneumatic Otoscopy

• Gold standard for clinical diagnosis
• Siegel's speculum — absent or reduced TM mobility confirms effusion
• Sensitivity 94%, specificity 80% (American Academy of Pediatrics guidelines)

B. Tympanometry (Immittance Audiometry)

         Type A (Normal)          Type B (Glue Ear)
              /\                   ___________
             /  \                 |           |
            /    \                |           |
  -400    0    +200 daPa        -400        +200 daPa

C. Audiometry

• Conductive hearing loss: Air-bone gap ≥ 15 dB
• Average HL: 25–40 dB across all frequencies
• Rising audiogram (low frequencies most affected)
• Bone conduction: Normal (confirms conductive nature)

AUDIOGRAM PATTERN IN GLUE EAR:

Frequency (Hz):  250   500  1000  2000  4000  8000
Air Conduction:   35    30    25    25    20    20  dB  (↑ elevated)
Bone Conduction:   5     5     5     5     5     5  dB  (Normal)
                  ↑_____________________________↑
                        AIR-BONE GAP
                  (indicates conductive hearing loss)

D. Acoustic Reflex

• Absent ipsilateral and contralateral acoustic reflex in Type B tympanogram

E. Otoacoustic Emissions (OAE)

• DPOAEs and TEOAEs: Reduced or absent
• Used for screening in neonates and young children
• Not specific for OME but indicates middle ear pathology

F. Wideband Acoustic Immittance (WAI) — Recent Advance

• More sensitive than conventional tympanometry (especially in neonates)
• Assesses energy absorbance across broader frequency range (226 Hz to 8000 Hz)

G. Imaging (Selected Cases)

• X-ray nasopharynx (lateral view): Adenoid enlargement
• HRCT temporal bone: Not routine; used when cholesteatoma or structural abnormality suspected
• MRI: Non-EPI DWI for cholesteatoma differentiation in chronic cases

---

10. DIAGNOSTIC ALGORITHM / FLOWCHART

CHILD WITH SUSPECTED HEARING LOSS / SPEECH DELAY
                    ↓
         HISTORY + PHYSICAL EXAMINATION
         (Otoscopy / Pneumatic Otoscopy)
                    ↓
    ┌───────────────┴────────────────┐
    │                                │
 NORMAL TM                    DULL, RETRACTED TM
    │                         Immobile on pneumatic otoscopy
    │                                ↓
    │                      TYMPANOMETRY
    │                ┌──────────────┴──────────────┐
    │              Type A                      Type B / Type C
    │           (Consider               (CONFIRMS MIDDLE EAR
    │           other causes)               EFFUSION / OME)
    │                                           ↓
    │                                     AUDIOMETRY (PTA)
    │                                  Air-Bone Gap ≥ 15 dB
    │                                  (Conductive HL)
    │                                           ↓
    │                               OBSERVE FOR 3 MONTHS
    │                          (Watchful Waiting + Autoinflation)
    │                                           ↓
    │                      ┌──────────────────┴──────────────────┐
    │               RESOLVED                            PERSISTS > 3 months
    │            (50% cases)                      HL > 25 dB, bilateral
    │                 ↓                                    ↓
    │          Reassure + Monitor                 SURGICAL INTERVENTION
    │                                        (Myringotomy + Grommet Insertion
    │                                        ± Adenoidectomy)
    │                                                   ↓
    │                                         POST-OP FOLLOW-UP
    │                                         (Audiometry at 3 months)
    └─────────────────────────────────────────────────────────────┘

---

11. DIFFERENTIAL DIAGNOSIS

⚠️ Important: Unilateral OME in adults must ALWAYS be investigated to exclude nasopharyngeal carcinoma (NPC).

---

12. MANAGEMENT

A. Watchful Waiting ("Watch and Wait" Policy)

• Spontaneous resolution rate: ~50% within 3 months, ~95% by 1 year
• NICE Guidelines (2023): Offer 3 months of watchful waiting before surgical referral
• AAP Guidelines (2023): Active surveillance q3 months

• Increases nasopharyngeal pressure → temporarily opens ET → clears effusion
• Evidence: RCT by Perera et al. (2013) showed benefit vs. no treatment

B. Medical Management

C. Surgical Management

Indications for Surgery (Scott-Brown's; NICE 2008/2023)

1. Bilateral OME persisting > 3 months with hearing loss ≥ 25 dBHL
2. Unilateral or bilateral hearing loss significantly affecting speech/language/learning
3. Bilateral hearing loss > 25 dB on PTA in better hearing ear
4. OME associated with significant retraction (risk of cholesteatoma)
5. Failure of conservative management
6. High-risk children: Down syndrome, cleft palate, sensorineural hearing loss

Surgical Options

• Most commonly performed pediatric surgery worldwide
• Procedure: Radial/antero-inferior myringotomy → aspiration of effusion → grommet insertion
• Types of grommets:

GROMMET INSERTION — SITES ON TYMPANIC MEMBRANE:

         SUPERIOR
    ___________________
   /  pars flaccida    \
  |  (AVOID — high risk)|
  |   Posterior        |      ← Posterior superior: risk to ossicles
  |   superior         |
  |   ┌─────────────┐  |
  |   │             │  |
  |   │   Antero-   │  |←── PREFERRED SITE for grommet
  |   │  inferior   │  |    (anterior inferior quadrant)
  |   │  quadrant   │  |
  |   └─────────────┘  |
   \___________________/
         INFERIOR

• Reduces adenoid biofilm reservoir (Haemophilus influenzae biofilm)
• Improves ET function by reducing obstruction
• Evidence: TARGET Trial (UK, 2004) — adenoidectomy + grommet more effective than grommet alone for resolution at 1 year
• Recommended if: adenoid hypertrophy, recurrent OME, age > 4 years
• Not recommended below age 2 years

• Temporary relief; fluid reaccumulates within weeks
• Use: In acute setting for pain relief or to send culture

• Alternative to surgery in children who refuse surgery
• Preferred in: Down syndrome (surgical risk), bilateral sensorineural HL, adults

---

13. SURGICAL FLOWCHART

CONFIRMED OME WITH HEARING LOSS > 25 dB (bilateral)
         Persistent > 3 months
                    ↓
          ASSESS RISK FACTORS
    ┌────────────────┴────────────────┐
    │                                 │
 HIGH-RISK CHILD                STANDARD RISK
(Down syndrome, cleft           (Healthy child)
 palate, speech delay)                ↓
    ↓                          AGE ASSESSMENT
 EXPEDITE SURGERY          ┌──────────┴──────────┐
 (Grommets ± HA)          < 4 years          ≥ 4 years
                               ↓                  ↓
                      GROMMETS ONLY       GROMMETS + ADENOIDECTOMY
                           ↓                       ↓
                   POST-OP AUDIOMETRY AT 3 MONTHS
                           ↓
          ┌────────────────┴────────────────┐
          │                                 │
     IMPROVED                          PERSISTS
   (Monitor 6-monthly)           LONG-TERM T-TUBE
                                 (Goode/Per-Lee)
                                 ± Re-adenoidectomy

---

14. COMPLICATIONS

Complications of Untreated OME

Grading of Tympanic Membrane Retraction — Sadé Classification (Scott-Brown's)

Complications of Grommet Insertion

---

15. STAGING / GRADING OF OME (Zakir Hussain; Dhingra's)

---

16. SPECIAL SITUATIONS

Glue Ear in Adults

• Less common; requires exclusion of:
  • Nasopharyngeal carcinoma (mandatory nasopharyngoscopy)
  • Skull base tumors
  • Barotrauma, post-radiation changes
• Management: ET dilation (balloon tuboplasty) as emerging option

Glue Ear in Cleft Palate

• Tensor veli palatini abnormality → permanent ET dysfunction
• Nearly 100% of cleft palate children develop OME
• Grommets at time of palate repair (standard of care)

Glue Ear in Down Syndrome

• Short, horizontal ET + immunological compromise
• High recurrence; long-term T-tubes preferred
• Hearing aids often used (surgical risk)

---

17. RECENT ADVANCES (RGUHS-relevant, 2018–2024)

1. Balloon Eustachian Tuboplasty (BET)

• FDA-approved (2016), gaining prominence
• Catheter-based balloon inflation of ET cartilaginous portion
• CETDIL study (Randomized, 2019): Significant improvement in ET function and tympanogram at 6 weeks vs. sham
• Suitable for adults with chronic ET dysfunction and OME
• Not yet standard in children

2. Biofilm and Microbiome Research

• Hall-Stoodley et al. (2006): 92% of chronic OME effusions contain bacterial biofilms even in "culture-negative" specimens
• Biofilm species: H. influenzae (predominant), S. pneumoniae, M. catarrhalis
• Implication: Explains antibiotic treatment failure; biofilm-disrupting agents under investigation
• Mucolytics with biofilm disruption (DNase, N-acetylcysteine) — experimental stage

3. Genetic and Epigenetic Factors

• GALNT genes mutations associated with increased OME susceptibility
• Complement pathway genes (CFH, CFHR) — association in genome-wide association studies (GWAS)
• TBX1 gene mutations: DiGeorge syndrome + OME

4. Wideband Tympanometry / Wideband Acoustic Immittance (WAI)

• Energy absorbance measured from 226 Hz to 8000 Hz
• More accurate than single-frequency (226 Hz) tympanometry, especially for infants
• Can detect OME in neonates with greater accuracy than conventional tympanometry

5. MUC Gene Targeting

• MUC5B and MUC5AC overexpression drives mucin hypersecretion
• Therapeutic targeting of MUC genes (siRNA, monoclonal antibodies) — in animal model research

6. Endoscopic Ear Surgery (EES) for Complicated OME

• Better visualisation of attic, retraction pockets, early cholesteatoma
• Transcanal endoscopic myringotomy gaining acceptance
• Avoids post-auricular incision

7. Probiotic Therapy

• Lactobacillus rhamnosus GG supplementation — reduces AOM recurrence rates
• Nasopharyngeal probiotics (Streptococcus salivarius K12) — reduced OME episodes in early trials

8. Intranasal Corticosteroids — Updated Evidence

• 2022 Cochrane Review: Intranasal corticosteroids show modest short-term benefit in OME (especially with comorbid allergic rhinitis); not recommended as standalone therapy
• Mometasone furoate — highest evidence among steroid sprays

9. Personalised / Precision Medicine Approach

• Biomarkers in middle ear effusion: IL-6, IL-1β, leukotriene levels predict resolution vs. persistence
• Predicting "surgical responders" using effusion proteomics

10. NICE 2023 Updated Guidelines

• Autoinflation devices (Otovent) recommended as first-line adjunct
• Hearing aids as equal alternative to grommets in selected cases
• Routine adenoidectomy not recommended under age 2 years

---

18. PATHOLOGY FLOWCHART — COMPLETE SUMMARY

PREDISPOSING FACTORS
(URTI, adenoids, allergy, craniofacial anomaly, smoking)
                    ↓
         EUSTACHIAN TUBE DYSFUNCTION
         (obstruction / failure of active opening)
                    ↓
         NEGATIVE MIDDLE EAR PRESSURE
                    ↓
    ┌───────────────┴───────────────┐
    ↓                               ↓
EARLY OME                     PERSISTENT OME
(Serous, thin fluid)          (Mucoid, thick "glue")
    ↓                               ↓
Transudation of               Goblet cell metaplasia
plasma proteins               Mucous gland hypertrophy
    ↓                         MUC5B, MUC5AC overexpression
RESOLVES 50%                  Biofilm formation (H. influenzae)
within 3 months                        ↓
                              CHRONIC VISCOUS EFFUSION
                                       ↓
                              COMPLICATIONS:
                         ┌─────────────────────────┐
                         ↓                         ↓
                   TM CHANGES              FUNCTIONAL EFFECTS
                (retraction, tympano-    (CHL 25–40 dB, speech
                 sclerosis, atelectasis,  delay, educational
                 cholesteatoma)           underachievement)

---

19. PROGNOSIS

• 75–90% of surgical grommets achieve hearing improvement to normal levels
• Long-term HL from OME alone (without complications): not expected if treated appropriately
• Children treated surgically show better QoL scores (OM8-30 questionnaire) at 12 months (MRC MUSIC trial)

---

20. KEY MNEMONIC AIDS

• G — GERD
• L — Low immunity (IgA deficiency, ciliary dyskinesia)
• U — URTI (viral)
• E — ET dysfunction
• E — Enlarged adenoids
• A — Allergy / Atopy
• R — Race (Inuit, Native American)

• G — Granulation tissue
• R — Retained tube
• O — Otorrhoea (commonest)
• M — Medialisation
• M — Myringosclerosis / Tympanosclerosis
• E — Early extrusion
• T — TM perforation (persistent)
• S — Sensorineural HL (rare)

---

SUMMARY TABLE — GLUE EAR AT A GLANCE

---

REFERENCES

1. Scott-Brown's Otorhinolaryngology, Head & Neck Surgery (8th Ed.) — Vol. 2, Chapter 238: Otitis media with effusion
2. Cummings Otolaryngology (7th Ed.) — Chapter 196: Otitis media and Eustachian tube dysfunction
3. Stell & Maran's Head and Neck Surgery — Chapter on chronic otitis media
4. Zakir Hussain's ENT Diseases — Chapter 5: Chronic non-suppurative otitis media
5. Dhingra's Diseases of Ear, Nose & Throat (7th Ed.) — Chapter 12: Secretory otitis media, pp. 81–88
6. Hazarika's Textbook of ENT & HNS — Chapter: Otitis Media with Effusion
7. Harrison's Principles of Internal Medicine (21st Ed.) — p. 1060
8. Bailey & Love's Short Practice of Surgery (28th Ed.) — p. 778
9. NICE Clinical Guideline NG91 (2008, updated 2023) — Surgical management of otitis media with effusion in children
10. American Academy of Pediatrics (AAP) Clinical Practice Guideline 2023 — Otitis Media with Effusion
11. Hall-Stoodley L et al. JAMA 2006 — Biofilm in OME
12. Perera R et al. BMJ 2013 — Autoinflation RCT
13. CETDIL Study 2019 — Balloon Eustachian tuboplasty

---

RGUHS Exam Note: For a 50-mark answer, this topic typically expects: definition + epidemiology (3M), pathophysiology + etiology (8M), clinical features (5M), diagnosis with tympanogram + audiogram diagrams (10M), management including surgical flowchart and grommet types (12M), complications (5M), recent advances (5M), prognosis (2M). Flowcharts and labeled diagrams carry 5–7 marks and should not be omitted.